Oral hydrogel nanoemulsion co-delivery system treats inflammatory bowel disease via anti-inflammatory and promoting intestinal mucosa repair.

J Nanobiotechnology · 2023 · PMC10436423 · PMID 37596598

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

The body weight of mice in the control group showed an increasing trend, and there was a significant difference between the CUR/EMO NE@SA group and the DSS group, indicating that the CUR/EMO NE@SA had a certain effect of weight recovery and pathological status improvement CUR/EMO NE@SA had better therapeutic efficacy than free drugs (Fig. 5 B, C).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.